Loading clinical trials...
Loading clinical trials...
Investigation of the Effect of Needle Thickness on Postdural Puncture Headache: a Prospective Randomized Study
The aim of this study is to compare the effect of spinal needle type on postdural puncture headache in patients who will undergo cesarean section. The main question\[s\] it aims to answer are: \[Does spinal needle thickness affect postdural puncture headache?\] \[What is the response of patients who develop postdural puncture headache to treatment?\] In cases accepting cesarean section operation under spinal anesthesia, different tables were used with spinal needles, and it will be questioned whether headache will develop in the first 15 days postoperatively. Postdural puncture headache after surgery will be described.
Our study was designed as a prospective randomized study. Patients aged 20-50 years who accepted cesarean section under elective spinal anesthesia were included in the study. randomized into 3 groups with 250 patients in each group: Group 1: Patients who underwent cesarean section under spinal anesthesia with 25 gauge spinal needle ( Pencan® 0.42 × 88 mm- G27 × 3½, B. Braun, Melsungen, Germany) Group 2: Patients who underwent cesarean section under spinal anesthesia with 26 gauge spinal needle ( Atraucan® 0.42 × 88 mm- G27 × 3½, B. Braun, Melsungen, Germany) Group 3: Patients who underwent cesarean section operation under spinal anesthesia with 27 gauge spinal needle ( Pencan ® 0.42 × 88 mm- G27 × 3½, B. Braun, Melsungen, Germany) Postdural puncture headache (PDPH) was evaluated by visiting patients who were discharged to the service after spinal anesthesia in the hospital for 24 hours, and by calling them within 15 days after discharge. Conservative and medical treatment was recommended for patients who developed PDPH, and the response of the patients to treatment was evaluated.
Age
20 - 50 years
Sex
FEMALE
Healthy Volunteers
Yes
Başakşehir Çam and Sakura City Hospital
Istanbul, Basaksehir, Turkey (Türkiye)
Start Date
February 1, 2022
Primary Completion Date
May 1, 2022
Completion Date
May 1, 2022
Last Updated
March 21, 2023
750
ACTUAL participants
Patients who underwent cesarean section under spinal anesthesia with 25 gauge spinal needle
PROCEDURE
Patients who underwent cesarean section under spinal anesthesia with 26 gauge spinal needle
PROCEDURE
Patients who underwent cesarean section operation under spinal anesthesia with 27 gauge spinal needle
PROCEDURE
Lead Sponsor
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
NCT06273683
NCT06258902
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06689930